- Home
- ASRT
as 12-18-2024 9:46am EST
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | LAKE FOREST |
| Market Cap: | 91.3M | IPO Year: | 1997 |
| Target Price: | $3.19 | AVG Volume (30 days): | 908.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.72 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.73 - $1.80 | Next Earning Date: | 11-11-2024 |
| Revenue: | $125,763,000 | Revenue Growth: | -25.77% |
| Revenue Growth (this year): | -18.54% | Revenue Growth (next year): | 1.84% |
Stock Insider Trading Activity of Assertio Holdings Inc. (ASRT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mason Heather L | ASRT | Director | Nov 18 '24 | Buy | $0.80 | 75,000 | $60,000.00 | 287,650 |
Latest Assertio Holdings Inc. News
ASRT Breaking Stock News: Dive into ASRT Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
GlobeNewswire
5 days ago
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
GlobeNewswire
6 days ago
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
GlobeNewswire
12 days ago
Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer
Simply Wall St.
a month ago
Assertio Holdings Third Quarter 2024 Earnings: Beats Expectations
Thomson Reuters StreetEvents
a month ago
Q3 2024 Assertio Holdings Inc Earnings Call
Associated Press Finance
a month ago
Assertio: Q3 Earnings Snapshot
GlobeNewswire
a month ago
Assertio Reports Third Quarter 2024 Financial Results
Compare ASRT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ASRT Assertio Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.